Title of article :
Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer: Abstracted from: Rocha Lima CM, Green MR, Rotche R et al. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherap
Author/Authors :
Yip، نويسنده , , Desmond and Goldstein، نويسنده , , David، نويسنده ,
